Emerge Diagnostics Receives Worldwide Patent for {Hardware} Elimination Surgical procedure Know-how

CARLSBAD, Calif., Sept. 8, 2022 /PRNewswire/ — Emerge Diagnostics Inc. has been issued a global patent utilizing the EFA: Technique for Figuring out if Surgically-Implanted {Hardware} Ought to be Eliminated.

The patent provides to Emerge’s deep mental property portfolio and is concentrated on addressing the usage of their EFA expertise on the website of {hardware} implementation to determine if surgical removing is critical. The patent was co-authored by Phil Reaston, CTO, Co-Founder Emerge Diagnostics, MaryRose Cusimano-Reaston, Ph.D. CSO, COO, Co-Founder Emerged Diagnostics, Frank Tomecek, MD, Affiliate Medical Director, Emerge Diagnostics.

The corporate’s expertise permits surgeons to extra objectively decide if spinal {hardware} must be eliminated, lowering the variety of second surgical procedures and bettering affected person outcomes. “This is a vital milestone for Emerge Diagnostics,” mentioned Co-Founder, COO Dr. Cusimano-Reaston “We’re dedicated to bringing our sufferers the very best care, and this expertise will assist us just do that.”

This patent can revolutionize how we deal with sufferers with surgically implanted {hardware}, by offering goal data that may assist surgeons decide if implants are nonetheless wanted or if they are often safely eliminated. The expertise has the potential to vary the usual of look after these sufferers, and displays our dedication to higher outcomes for all.

Right now’s announcement is a praise to Emerge’s portfolio of well being options providing 360° care to staff, and their relations. Emerge Wellness options embody preventative care for workers and their households and a now a primary of its variety patent for figuring out if surgically-implanted {hardware} must be eliminated.

Musculoskeletal circumstances are the main healthcare value for workers, their relations, well being plans and employers. The system is over prescribing painkillers and elective surgical procedures, whereas failing to supply preventative care or non-surgical options. Lowering waste and bettering outcomes is vital for everybody.

About Emerge Diagnostics

Emerge Diagnostics, a medical options firm dedicated to protecting employees and their households secure—each on the job and off—by stopping damage and orchestrating restoration.

The corporate’s Electrodiagnostic Useful Evaluation (EFA) expertise is the gold commonplace for soft-tissue damage prognosis and therapy, utilizing a number of proprietary applied sciences to evaluate root causes—and from just about anyplace on this planet. Emerge Diagnostics serves shoppers in a number of industries, together with trucking, healthcare and sports activities, offering the knowledge essential to deal with soft-tissue accidents extra precisely and construct care administration and monitoring applications rooted in goal information: www.emergedx.com.

If in case you have any questions or would really like extra data, please contact us at [email protected].

SOURCE Emerge Diagnostics

Emerge Diagnostics Receives Worldwide Patent for {Hardware} Elimination Surgical procedure Know-how